Clinical Trial Update: "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MetCool ACS evaluating Metformin 'cooling' effect in metformin-naive patients treated with PCI for Acute Coronary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• MetCool ACS (Metformin)
• metformin (metformin)

Snippet

Sponsor: Military Institute od Medicine National Research Institute | Conditions: Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN